It’s just ridiculous that this economic research is being used to achieve a regulated reimbursement code with the American Medical Association, who would be fully aware of the impact of DKD on the USA health economy, but God forbid, don’t use it to inform investment decisions on the ASX!
Are they making an assumption investors can’t read properly? I understand that the ASX have had to regulate rampy & misleading ANNs, but this modelling was actually on the conservative side. It’s a shame that this has happened, but it doesn’t change anything in the big scheme of things for PromarkerD.
GLTAH
PIQ Price at posting:
92.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)